CUSIP 670002401COM NEWNVAXQ4 2025
36 filings · latest Feb 11, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Vanguard Group Inc | 15.47M | $103.96M |
| 2 | Shah Capital Management | 14.56M | $97.84M |
| 3 | Blackrock, Inc. | 12.90M | $86.70M |
| 4 | State Street Corp | 9.52M | $64.00M |
| 5 | Bank Of America Corp /De/ | 8.29M | $55.71M |
| 6 | Sanofi | 6.88M | $46.24M |
| 7 | D. E. Shaw & Co., Inc. | 5.99M | $40.27M |
| 8 | Ubs Group AG | 4.89M | $32.89M |
| 9 | Millennium Management LLC |
| 4 | Oct 14, 2025 | Shah Capital Management | 13D/A | 7.3% | — | SEC |
| 5 | Feb 5, 2025 | Blackrock, Inc. | 13G/A | 8.4% | 13.45M | SEC |
| 6 | Nov 12, 2024 | Vanguard Group Inc | 13G/A | 9.6% | 15.43M | SEC |
| 7 | Nov 4, 2024 | Vanguard Group Inc | 13G/A | 9.6% | 15.43M | SEC |
| 8 | Jul 10, 2024 | State Street Corp | 13G/A | 4.3% | — | SEC |
| 9 | Jun 20, 2024 | Sk Bioscience Co., Ltd. | 13G/A | 4.6% | 6.50M | SEC |
| 10 | May 20, 2024 | Shah Capital Management | 13D/A | 7.8% | 10.97M | SEC |
See the full Schedule 13D/13G history for Novavax Inc.
Unlock full history| 4.47M |
| $30.04M |
| 10 | Geode Capital Management, LLC | 3.72M | $25.01M |